Abstract: A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.
Type:
Grant
Filed:
June 12, 2014
Date of Patent:
April 19, 2016
Assignee:
Yeda Research and Development Co., Ltd.
Inventors:
Michal Eisenbach-Schwartz, Ester Yoles, Ravid Shechter, Omer Miller
Abstract: A first aspect of the invention relates to the bacterial species Roseburia hominis for use in: regulating the immune system of a subject treating an immune disorder; treating an intestinal disorder; improving intestinal microbiota; regulating the innate immune system of a subject; regulating the adaptive immune system of a subject; regulating appetite in a subject; promoting Tregs and immune tolerance; promoting gut health in a subject; and/or maintaining immune homeostasis in a subject. Further aspects of the invention relate to compositions comprising Roseburia hominis.
Abstract: The present invention is directed to methods of treating an organ or a tissue prior to transplantation thereof into a recipient, comprising ablating the cells composing the blood vessels of said organ or tissue, preferably the cells lining the lumen surface of the blood vessels, thereby obtaining a treated viable organ or tissue having reduced immunogenicity. The invention is also directed to treated viable organs or tissues having reduced immunogenicity and uses thereof.
Abstract: This invention relates to an antimicrobial susceptibility test made upon pure microbial cultures—a laboratory culture containing a single species of organism—or directly from biological samples uncultured. Some preferred embodiments do not require the use a pure culture obtained from a biological product which would otherwise take at least 24 hours for the microorganisms to grow—so, is performed an antimicrobial susceptibility test directly from uncultured biological samples like urine, blood cultures or water by fluorescence analysis.
Type:
Grant
Filed:
June 4, 2012
Date of Patent:
March 22, 2016
Assignee:
UNIVERSIDADE DO PORTO
Inventors:
Cidália Irene Azevedo Pina Vaz, Acácio Agostinho Goncalves Rodrigues, Isabel Cristina Santos Silva De Faria Ramos Antunes, Ana Sofia Quinta E Costa De Oliveira Morais, Ana Teresa Pinto E Silva, Ana Isabel Silva Dias, Rita Daniela Teixeira Dos Santos
Abstract: The present invention relates to a method for processing isolated cells, in particular rare cells such as circulating tumor cells, to render them suitable for optical imaging, comprising the steps of (a) depositing filter material comprising captured cells on a phase-change medium; (b) melting said phase-change medium until the medium is spread out below said filter material; and (c) lowering the temperature of said phase-change medium until the medium solidifies, resulting in an optically flat filter comprising said cells at a fixed position. The method may additionally comprise an initial step of capturing a cell on a filter material. The phase-change medium, preferably paraffin wax, may comprise a porous, or mesh-like structure allowing the passage of a fluid through the medium. The phase-change medium may further be mounted on a carrier such as a glass carrier or a polymer material carrier.
Type:
Grant
Filed:
July 4, 2012
Date of Patent:
March 22, 2016
Assignee:
Koninklijke Philips N.V.
Inventors:
Menno Willem Jose Prins, Mikhail Mikhaylovich Ovsyanko, Freek Van Hemert, Arie Rombertus Van Doorn
Abstract: The present invention provides, among other things, methods for the characterization of recombinant Heparan N-Sulfatase (HNS) during manufacture. The present invention uses capillary zone electrophoresis to determine the charge profile, isoform distribution, and/or glycan profile of recombinant HNS; and represents a quality feature for the batch consistency, storage stability, biological half-life, pharmacokinetic, pharmacodynamic and biological activity of the enzyme. In particular, such characterization methods may be beneficial to optimize conditions and ensure consistency for the manufacture of HNS for the treatment of a patient diagnosed with Sanfilippo syndrome using enzyme replacement therapy.
Abstract: A method and system for collecting leukoreduced red blood cells employing a spinning membrane separator including a housing having an upper end region and a lower end region in an operating position with a red blood cell outlet in the upper end region of the housing and a whole blood inlet in the lower end region of the housing. The method and system provide for flowing additive solution into the whole blood inlet of the housing to prime the separator; flowing whole blood into the whole blood inlet of the housing; separating red blood cells from the whole blood; flowing separated red blood cells out of the red blood cell outlet of the housing; combining the separated red blood cells with additive solution; passing the separated red blood cells and additive solution combination through a leukoreduction filter; and collecting the filtered red blood cells and additive solution.
Type:
Grant
Filed:
February 18, 2015
Date of Patent:
March 15, 2016
Assignee:
Fenwal, Inc.
Inventors:
Benjamin Kusters, Christopher Wegener, Kyungyoon Min
Abstract: Methods and kits for enzymes involved in post-translational modifications are provided. The methods employ elemental analysis, including ICP-MS. The methods allow for the convenient and accurate analysis of post-translation modifications of substrates by enzymes involved in post-translational modifications, including kinase and phosphatase enyzmes.
Abstract: Methods and kits for enzymes involved in post-translational modifications are provided. The methods employ elemental analysis, including ICP-MS. The methods allow for the convenient and accurate analysis of post-translation modifications of substrates by enzymes involved in post-translational modifications, including kinase and phosphatase enyzmes.
Abstract: A blood processing system and method are disclosed that comprise a leukoreduction filter for removing leukocytes from red blood cells as the red blood cells pass through the filter; and a pump for pumping an additive solution through the leukoreduction filter to flush the leukoreduction filter of red blood cells that remain in the leukoreduction filter after filtration of the red blood cells. Additive solution is flowed through the leukoreduction filter at an initial flush rate to flush remaining red blood cells from the leukoreduction filter and the pump increases the flush rate of the additive solution during flushing of the leukoreduction filter.
Type:
Grant
Filed:
February 18, 2015
Date of Patent:
March 8, 2016
Assignee:
Fenwal, Inc.
Inventors:
Benjamin Kusters, Christopher Wegener, Kyungyoon Min
Abstract: The present invention provides method of detecting a predetermined biological activity. The method includes using an aqueous mixture comprising a first indicator reagent with a first absorption spectrum and a second indicator reagent. The second indicator reagent is converted by the predetermined biological activity to a second biological derivative with a second emission spectrum. The first absorbance spectrum includes detectable absorbance in at least a portion of wavelengths present in the second emission spectrum. The first indicator reagent is received and concentrated from an aqueous liquid by a substrate, facilitating the detection of the second biological derivative.
Type:
Grant
Filed:
August 7, 2014
Date of Patent:
March 8, 2016
Assignee:
3M Innovative Properties Company
Inventors:
Sailaja Chandrapati, Heather M. Webb, Jeffrey C. Pederson, Kurt J. Halverson, Brian J. Engel
Abstract: An essentially glutamine-free medium comprising a whole-cell glutamine biosensor, comprising a glutamine auxotrophic E. coli and a Lux reporter gene, for detecting glutamine in an analyte. The medium is useful in methods to detecting, screening, identifying and selecting nitrogen-fixing microbes and in methods of determining the nitrogen state of plants, plant products and soil.
Type:
Grant
Filed:
June 20, 2012
Date of Patent:
March 8, 2016
Assignee:
University of Guelph
Inventors:
Manish Raizada, Michael Tessaro, Hanan Reda Hassan Elsayed Shehata
Abstract: A cell sorter including a well that has a microspace filled with a liquid and having a typical length of 1 mm or less, and that has a bottom surface made of a light-permeable material allowing optical observation of an interior of the microspace; a matrix provided on the bottom surface in the well; a bone fragment placed on the matrix in the well; and osteoclasts placed between the matrix and the bone fragment.
Abstract: An in vitro cell assay for detecting an effect a test condition has on one or more cells. The assay comprises providing a binary half-adder system comprising first and second oscillating cells, and detecting an effect a test condition has on the oscillation of said first and/or second cells.
Type:
Grant
Filed:
March 31, 2014
Date of Patent:
March 1, 2016
Assignee:
Manchester Metropolitan University
Inventors:
Stephen Lynch, Jon Borresen, Mark Slevin
Abstract: Provided herein are techniques for identification of viable and nonviable cells in a cell culture that include measuring a resonance impedance spectral response of at least one resonator in proximity to the cell culture and correlating the measured response to the concentration of viable cells in cell culture and/or the concentration of nonviable cells in cell culture.
Type:
Grant
Filed:
December 30, 2013
Date of Patent:
March 1, 2016
Assignee:
GENERAL ELECTRIC COMPANY
Inventors:
Radislav A. Potyrailo, Victoria E. Cotero, Jon A. Dieringer, Thomas J. Erdenberger, Timothy A. Wortley
Abstract: A method of detecting a target microorganism is disclosed. The method comprises providing a culture device with a selective culture medium and a detection article comprising a first indicator system. The selective culture medium facilitates the growth of an indicator microorganism. When an indicator microorganism is detected in a sample contacted with the culture medium, the detection article is contacted with the culture medium to detect the target microorganism.
Type:
Grant
Filed:
December 23, 2011
Date of Patent:
March 1, 2016
Assignee:
3M Innovative Properties Company
Inventors:
Takatoshi Moriyama, Patrick A. Mach, Akio Kitahara, Henry J. Lubrant
Abstract: The present invention relates to aminoclay, for harvesting algae, which is prepared by fixing aminosilane around cationic metal ions through a sol-gel reaction. Also, the present invention relates to a method for harvesting algae using the aminoclay according to any one selected from the above methods.
Type:
Grant
Filed:
March 13, 2012
Date of Patent:
February 23, 2016
Assignee:
KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors:
Wasif Farooq, Young-Chul Lee, Ji-Won Yang
Abstract: Provided is an assay method using an encoded particle-based platform. In the assay method, first, a plurality of encoded particles having codes distinguishable from one another according to kinds of included target materials are prepared. The plurality of encoded particles are provided onto a plate including a plurality of wells by pipetting, and disposed in the plurality of wells by a self-assembly method. An analyte is provided into the plurality of wells. The codes of the plurality of encoded particles disposed in the plurality of wells are decoded. The target materials of the plurality of encoded particles are released to cause a reaction between the target materials and the analyte.
Type:
Grant
Filed:
January 13, 2014
Date of Patent:
February 23, 2016
Assignee:
SNU R&DB FOUNDATION
Inventors:
Sung Hoon Kwon, Su Eun Chung, Sung Hoon Lee, Wook Park, Young Hoon Song